1. Home
  2. RDI vs GBIO Comparison

RDI vs GBIO Comparison

Compare RDI & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDI
  • GBIO
  • Stock Information
  • Founded
  • RDI 1937
  • GBIO 2016
  • Country
  • RDI United States
  • GBIO United States
  • Employees
  • RDI N/A
  • GBIO N/A
  • Industry
  • RDI Movies/Entertainment
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDI Consumer Discretionary
  • GBIO Health Care
  • Exchange
  • RDI Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • RDI 30.1M
  • GBIO 29.2M
  • IPO Year
  • RDI N/A
  • GBIO 2020
  • Fundamental
  • Price
  • RDI $1.38
  • GBIO $0.38
  • Analyst Decision
  • RDI Hold
  • GBIO Strong Buy
  • Analyst Count
  • RDI 1
  • GBIO 4
  • Target Price
  • RDI $2.40
  • GBIO $7.33
  • AVG Volume (30 Days)
  • RDI 38.2K
  • GBIO 476.6K
  • Earning Date
  • RDI 05-15-2025
  • GBIO 05-07-2025
  • Dividend Yield
  • RDI N/A
  • GBIO N/A
  • EPS Growth
  • RDI N/A
  • GBIO N/A
  • EPS
  • RDI N/A
  • GBIO N/A
  • Revenue
  • RDI $205,644,000.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • RDI $9.74
  • GBIO N/A
  • Revenue Next Year
  • RDI $6.39
  • GBIO N/A
  • P/E Ratio
  • RDI N/A
  • GBIO N/A
  • Revenue Growth
  • RDI N/A
  • GBIO 146.47
  • 52 Week Low
  • RDI $1.17
  • GBIO $0.32
  • 52 Week High
  • RDI $1.89
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • RDI 52.10
  • GBIO 45.45
  • Support Level
  • RDI $1.34
  • GBIO $0.37
  • Resistance Level
  • RDI $1.49
  • GBIO $0.41
  • Average True Range (ATR)
  • RDI 0.08
  • GBIO 0.03
  • MACD
  • RDI 0.00
  • GBIO 0.00
  • Stochastic Oscillator
  • RDI 32.35
  • GBIO 28.93

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: